Since the 1950s, researchers have used a famous method invented by Wallace Coulter known as “flow cytometry” to characterize different types of immune cells in research studies and in blood samples from human individuals.
Erasca’s ERAS-801 secures FDA orphan drug designation
Erasca’s ERAS-801 will be used to treat malignant glioma, including glioblastoma. Credit: Nemes Laszlo / Shutterstock.com. Erasca has obtained orphan drug designation (ODD) from the
June 23, 2023